Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 200 for “"HDAC Inhibitors"”.

  1. HR23B, a biomarker for HDAC inhibitors

    … through targeting histone deacetylase (HDAC) has led to the introduction of many HDAC inhibitors. To date, two have had regulatory approval for the treatment of cutaneous T cell lymphoma (CTCL). Modifications in chromatin control underpin the mechanism of action of HDAC inhibitors. A …

    oxford Repository record for HR23B, a biomarker for HDAC inhibitors (opens in a new tab)

  2. Structural and binding characterization of dual BET/HDAC inhibitors

    … and Extra Terminal) των bromodomains και οι HDAC (Histone deacetylases), αντίστοιχα. Ο κρίσιμος ρόλος τους σε πολλαπλές κυτταρικές διεργασίες και κατ’ επέκταση η διαταραγμένη έκφραση και λειτουργία τους εμπλέκονται σε μια πληθώρα παθολογιών – συχνά επικαλυπτόμενων για τις δύο αυτές κατηγορίες …

    athens Repository record for Structural and binding characterization of dual BET/HDAC inhibitors (opens in a new tab)

  3. Synthesis of novel potential HDAC inhibitors based on multicomponent reactions

    Multicomponent reactions (MCRs) provide valuable opportunities for the synthesis of a wide range of heterocyclic compounds, many of which exhibit significant biological activity and unique physical properties. Compared with traditional step-by-step synthetic methods, MCRs represent a powerful tool …

    freiburg-diss Repository record for Synthesis of novel potential HDAC inhibitors based on multicomponent reactions (opens in a new tab)

  4. Depletion of Dormant Hormone-Sensitive Breast Cancer Cells Using HDAC Inhibitors

    … models, we identified a histone deacetylase (HDAC)-mediated epigenetic vulnerability that enables selective targeting of CSPs under ET conditions. Live-cell imaging confirmed the direct killing of CSPs, while protein expression studies revealed that HDAC inhibition disrupts the balance of pro- …

    umn Repository record for Depletion of Dormant Hormone-Sensitive Breast Cancer Cells Using HDAC Inhibitors (opens in a new tab)

  5. Design, Synthesis, And Evaluation Of Class Iia Histone Deacetylase (hdac) Inhibitors

    Histone deacetylase (HDAC) proteins are linked to disease states, including cancer, and have become important targets for therapeutic development. Many inhibitors have been developed to target HDAC proteins, including FDA-approved inhibitors Vorinostat (SAHA), Belinostat, Romidepsin, and …

    wayne-thes Repository record for Design, Synthesis, And Evaluation Of Class Iia Histone Deacetylase (hdac) Inhibitors (opens in a new tab)

  6. The Design, Synthesis, And Biological Evaluation Of Selective Histone Deacetylase (hdac) Inhibitors

    Histone deacetylase (HDAC) proteins have become an important target for the treatment of several diseases including cancers, neurodegenerative diseases and inflammatory diseases. Four such inhibitors are approved by the FDA as anti-cancer drugs, but unfortunately, they inhibit numerous HDAC …

    wayne-thes Repository record for The Design, Synthesis, And Biological Evaluation Of Selective Histone Deacetylase (hdac) Inhibitors (opens in a new tab)

  7. Integration of class 1 HDAC inhibitors into current treatments for prostate cancer

    … prostate cancer (CRPC). Androgen signalling inhibitors (ASI), including Enzalutamide (ENZ) and Abiraterone (ABI), are effective treatments for metastatic CRPC however, resistance develops within 24-months of initial exposure in the majority of patients. <br/><br/>Epigenetic silencing of …

    qu-belfast Repository record for Integration of class 1 HDAC inhibitors into current treatments for prostate cancer (opens in a new tab) Download PDF for Integration of class 1 HDAC inhibitors into current treatments for prostate cancer (opens in a new tab)

  8. Exploring TLR adaptor protein MyD88 as a sensitivity determinant to HDAC inhibitors

    … as epigenetic processes. Histone Deacetylase (HDAC) inhibitors, a class of therapeutic agents developed against the latter, have been shown to be efficient against certain haematological malignancies. However, the underlying molecular mechanisms are still largely unknown. An unbiased …

    oxford Repository record for Exploring TLR adaptor protein MyD88 as a sensitivity determinant to HDAC inhibitors (opens in a new tab)

  9. Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors

    … drugs that inhibit histone deacetylase (HDAC) proteins. HDACs are histone modifying enzymes that regulate transcription of genes. Aberrant recruitment of HDACs to the transcription factors leads to tumor onset and growth. Because of their potential anti-cancer therapeutic interest, …

    wayne-thes Repository record for Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors (opens in a new tab)

  10. Charakterisierung der Wirkmechanismen des neuartigen, dual wirksamen HDAC-Inhibitors „Animacroxam“ am Beispiel testikulärer Keimzelltumore

    … bestehend aus einer Histonedeacetylase- (HDAC) und einer Zytoskelett-inhibierenden Pharmacophore, auf ihre Wirksamkeit in testikulären Keimzelltumoren untersucht. Die Wirkung von Animacroxam wurde dabei mit der Wirksamkeit des Goldstandards in der TKZT-Therapie Cisplatin und dem klinisch …

    fu-berlin Repository record for Charakterisierung der Wirkmechanismen des neuartigen, dual wirksamen HDAC-Inhibitors „Animacroxam“ am Beispiel testikulärer Keimzelltumore (opens in a new tab)

  11. Rationalising the inclusion of HDAC inhibitors with standard-of-care chemotherapy for high-risk neuroblastoma

    … priming with the histone deacetylase (HDAC) inhibitor vorinostat could overcome this chemoresistance and sensitise tumours to treatment with specific standard-of-care chemotherapies. In order to further rationalise the inclusion of HDAC inhibitors with a wider range of standard-of-care …

    unsw Repository record for Rationalising the inclusion of HDAC inhibitors with standard-of-care chemotherapy for high-risk neuroblastoma (opens in a new tab) Embargoed

  12. Einfluss und Wirkung des HDAC-Inhibitors LBH589 auf Proliferation und Differenzierung der kolorektalen Karzinomzelllinien SW480 und SW620

    … war es, die Auswirkungen des Histondeacetylase-Inhibitors LBH589 auf Proliferation und Differenzierung von Kolonkarzinomzellen und dessen Metastasenzellen in Zellkulturexperimenten zu untersuchen. Die Untersuchungen wurden an Zellen der Zellkulturlinien SW480 (kolorektales Karzinom) und SW620 …

    wurz-thes Repository record for Einfluss und Wirkung des HDAC-Inhibitors LBH589 auf Proliferation und Differenzierung der kolorektalen Karzinomzelllinien SW480 und SW620 (opens in a new tab)

  13. THE NATURAL POLYPHENOL RESVERATROL POTENTIATES THE LETHALITY OF HDAC INHIBITORS IN ACUTE MYELOGENOUS LEUKEMIA CELLS THROUGH MULTIPLE MECHANISMS.

    … between the natural polyphenol Resveratrol and HDAC inhibitors in both U937 myelomonocytic leukemia cell line and blood samples from AML patients and normal cord blood. Simultaneous exposure to Resveratrol and HDAC inhibitors (Vorinostat-SAHA or Panobinostat-LBH589) resulted in potentiating the …

    vcu Repository record for THE NATURAL POLYPHENOL RESVERATROL POTENTIATES THE LETHALITY OF HDAC INHIBITORS IN ACUTE MYELOGENOUS LEUKEMIA CELLS THROUGH MULTIPLE MECHANISMS. (opens in a new tab)

  14. Design, Synthesis And Biological Evaluation Of Histone Deacetylase (hdac) Inhibitors: Saha (vorinostat) Analogs And Biaryl Indolyl Benzamide Inhibitors Display Isoform Selectivity

    HDAC proteins have emerged as interesting targets for anti-cancer drugs due to their involvement in cancers, as well as several other diseases. Several HDAC inhibitors have been approved by the FDA as anti-cancer drugs, including SAHA (suberoylanilide hydroxamic acid, Vorinostat). Unfortunately, …

    wayne-thes Repository record for Design, Synthesis And Biological Evaluation Of Histone Deacetylase (hdac) Inhibitors: Saha (vorinostat) Analogs And Biaryl Indolyl Benzamide Inhibitors Display Isoform Selectivity (opens in a new tab)

  15. The structural requirements of histone deacetylase (hdac) inhibitors: suberoylanilide hydroxamic acid (saha) analogues modified at c3, c6, and c7 positions enhance selectivity

    Histone deacetylase (HDAC) proteins are targets for drug design towards the treatment of cancers since overexpression of HDAC is linked to cancer. Several HDAC inhibitors, including the FDA approved drug suberoylanilide hydroxamic acid (SAHA, Vorinostat), have cleared clinical trials and emerged as …

    wayne-thes Repository record for The structural requirements of histone deacetylase (hdac) inhibitors: suberoylanilide hydroxamic acid (saha) analogues modified at c3, c6, and c7 positions enhance selectivity (opens in a new tab)

  16. Development of chemical inducers of dimerization for screening competitive histone deactelyase inhibitors

    Histone Deacetylase (HDAC) proteins are transcriptional regulators that affect histone proteins, which are involved in packaging of DNA into chromosomes. HDACs have been linked to the proliferation of cancer through their role in transcriptional regulation. Due to these findings, HDAC inhibitors …

    wayne-thes Repository record for Development of chemical inducers of dimerization for screening competitive histone deactelyase inhibitors (opens in a new tab)

  17. THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE

    … between the proteasome inhibitor carfilzomib and HDAC inhibitors were examined in both germinal center (GC) and activated B-cell (ABC) subtypes of human diffuse large B-cell lymphoma (DLBCL). Simultaneous exposure to minimally toxic concentrations of carfilzomib and HDAC inhibitor vorinostat …

    vcu Repository record for THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE (opens in a new tab)

  18. Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment

    … in tumourigenesis. Histone deacetylases (HDACs) are enzymes that regulate acetylation of chromatin and a variety of other non-histone substrates. Significantly, HDAC inhibitors are potent anti-proliferative agents and exhibit clinical activity in lymphoproliferative and haematological …

    oxford Repository record for Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment (opens in a new tab)

Page 1 of 10